Sun Pharma, Philogen join hands to commercialise skin cancer drug in Europe, Australia, New Zealand

Sun Pharma, Philogen join hands to commercialise skin cancer drug in Europe, Australia, New Zealand The companies have come together to commercialise Philogen#39;s speciality product Nidlegy, an anti-cancer biopharmaceutical currently in Phase III clinical trials, Sun Pharma said in a statement.

from Moneycontrol Business News https://ift.tt/mKn6AOI
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...